Janardan Pandey to Cetuximab
This is a "connection" page, showing publications Janardan Pandey has written about Cetuximab.
Connection Strength
0.191
-
Mechanism of resistance to cetuximab therapy in colorectal cancer: Possible role of antibodies to immunoglobulin allotypes. MAbs. 2012 Sep-Oct; 4(5):553-4.
Score: 0.097
-
Differential inhibition of trastuzumab- and cetuximab-induced cytotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes. Clin Exp Immunol. 2011 Dec; 166(3):361-5.
Score: 0.093